TRLV - Trulieve Cannabis Corp.
Price:
--
--
|
PRICE TARGET:
$15.00
DETAILS
HIGH:
$15.00
LOW:
$15.00
MEDIAN:
$15.00
CONSENSUS:
$15.00
UPSIDE:
81.38%
| Metric | 2025 |
|---|---|
| Revenue | |
| Revenue | 1,181.2 |
| Cost of Revenue | 470.0 |
| Gross Profit | 711.2 |
| Operating Expenses | |
| R&D Expenses | 0 |
| SG&A Expenses | 445.2 |
| Other Expenses | 117.6 |
| Operating Expenses | 562.8 |
| Operating Income | |
| Operating Income | 148.3 |
| Interest Expense | 63.5 |
| Interest Income | 14.5 |
| Profitability | |
| EBITDA | 328.3 |
| EBIT | 154.9 |
| Income Before Tax | 91.5 |
| Income Tax Expense | 208.1 |
| Net Income | (116.4) |
| Per Share Data | |
| EPS (Basic) | -0.61 |
| EPS (Diluted) | -0.61 |
| Shares Outstanding | 191.3 |
| Metric | 2025 |
|---|---|
| Current Assets | |
| Cash & Cash Equivalents | 255.5 |
| Short-Term Investments | 0 |
| Net Receivables | 20.2 |
| Inventory | 242.3 |
| Other Current Assets | 26.4 |
| Total Current Assets | 562.7 |
| Non-Current Assets | |
| Property, Plant & Equipment | 838.7 |
| Goodwill | 483.9 |
| Intangible Assets | 798.4 |
| Long-Term Investments | 0 |
| Other Non-Current Assets | 12.4 |
| Total Non-Current Assets | 2,133.4 |
| Total Assets | 2,696.1 |
| Current Liabilities | |
| Account Payables | 26.8 |
| Short-Term Debt | 4.1 |
| Deferred Revenue | 9.6 |
| Other Current Liabilities | 25.7 |
| Total Current Liabilities | 126.9 |
| Non-Current Liabilities | |
| Long-Term Debt | 227.6 |
| Deferred Tax Liabilities | 178.0 |
| Other Non-Current Liabilities | 714.8 |
| Total Non-Current Liabilities | 1,426.1 |
| Total Liabilities | 1,553.1 |
| Stockholders' Equity | |
| Common Stock | 0 |
| Retained Earnings | (912.1) |
| Accumulated Other Comprehensive Income | 0 |
| Total Stockholders' Equity | 1,161.2 |
| Total Liabilities & Equity | 2,696.1 |
| Debt Metrics | |
| Total Debt | 563.6 |
| Net Debt | 308.1 |
| Metric | 2025 |
|---|---|
| Operating Activities | |
| Net Income | (122.2) |
| Depreciation & Amortization | 173.4 |
| Stock-Based Compensation | 20.5 |
| Change in Working Capital | 188.2 |
| Other Non-Cash Items | 31.6 |
| Operating Cash Flow | 272.8 |
| Investing Activities | |
| Capital Expenditure | (60.5) |
| Acquisitions | 0 |
| Purchases of Investments | 0 |
| Sales/Maturities of Investments | 60 |
| Other Investing Activities | (2.3) |
| Investing Cash Flow | 13.5 |
| Financing Activities | |
| Net Debt Issuance | (393.3) |
| Stock Repurchased | 0 |
| Dividends Paid | 0 |
| Other Financing Activities | (17.1) |
| Financing Cash Flow | (270.5) |
| Cash Position | |
| Net Change in Cash | 15.8 |
| Cash at Beginning | 239.7 |
| Cash at End | 255.5 |
| Free Cash Flow | 212.3 |
| Key Metrics | 2025 |
|---|---|
| Income Statement | |
| Revenue | 1,181.2 |
| Gross Profit | 711.2 |
| Operating Income | 148.3 |
| Net Income | (116.4) |
| EPS (Diluted) | -0.61 |
| Balance Sheet | |
| Cash & Equivalents | 255.5 |
| Total Assets | 2,696.1 |
| Total Debt | 563.6 |
| Stockholders' Equity | 1,161.2 |
| Cash Flow | |
| Operating Cash Flow | 272.8 |
| Capital Expenditure | (60.5) |
| Free Cash Flow | 212.3 |